MedPath

GLN-EZETIMIBE

GLN-EZETIMIBE

Approved
DIN Number

02460750

Drug Class

Human

Market Date

Jul 23, 2019

Company
HC

glenmark pharmaceuticals canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02460750
AIG Number0149164001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C10AX09 EZETIMIBE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:06.05
Health Canada Classification

ACTIVE INGREDIENTS (1)

EZETIMIBEActive
Strength: 10 MG
Monograph: EZETIMIBE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.